Regeneron says study shows its monoclonal antibody cocktail works against coronavirus variants

Tests on two different variants of the coronavirus show that one of the two monoclonal antibodies in Regeneron’s cocktail therapy can neutralize both, despite the mutations, researchers reported Wednesday.